Fourteen Israeli life sciences and digital health companies presented their technologies to investors and strategic partners in the United States this week at the second Mini MIXiii conference in Miami, underscoring ongoing efforts to strengthen ties between Israeli innovators and the American healthcare ecosystem.
The event, organized by the Israel Advanced Technology Industries Association (IATI), featured startups selected to highlight cutting‑edge developments in biotechnology, diagnostics, personalized medicine, medical devices and data‑driven health technologies.
1 View gallery
Natan Tzur, economic attaché in New York and head of the economic mission of the Foreign Trade Administration to the US East Coast; Siobhan L. Harris, secretary of the Florida Agency for Health Care Administration; and Karin Mayer Rubinstein, CEO and president of the Israel Advanced Technology Industries Association (IATI)
(Photo: Nissim Harush)
The companies taking part included Pluri, Biond Biologics, Compugen, IceCure Medical, MediWound, SpliSense, Latica, OCUVIA, PhenoTA, Agile MRI, QuantalX Neuroscience, GrayMatters Health, Cytora and Bsense Bio Therapeutics Ltd.
“Our conference in Miami is part of the Association’s expanding international activity, aimed at strengthening Israel’s position on the global stage, deepening meaningful strategic partnerships and restoring the confidence of investors and international partners in the Israeli ecosystem following the war period,” IATI CEO and President Karin Mayer Rubinstein said in a statement.
She said the association works to “promote global activity and create meaningful strategic collaborations with the American and global ecosystems, thereby putting into practice its role in creating business certainty and continuity for Israel’s innovation industry, and in retelling the story of Israeli high-tech to the world.”
The Mini MIXiii conference, held in Miami’s Wynwood neighborhood, is a complementary event to IATI’s annual MIXiii Health‑Tech.IL conference in Jerusalem. This year’s flagship conference — the largest since the end of the war — is scheduled for March 17–18 and will draw global attendees.
The Miami event aimed to build bridges between Israeli startups and the U.S. healthcare sector, with participants seeking research collaborations, pilot programs, clinical trials and investment opportunities. Attendees from the Miami area included leaders from local hospitals, life sciences companies and investment firms.
The conference opened with remarks from senior U.S. and Israeli officials, including Siobhan Harris, secretary of the Florida Agency for Health Care Administration, and Robert Harvey, president and CEO of the Florida Opportunity Fund.
Representatives of Israel’s diplomatic and economic missions, including Natan Tzur, head of Israel’s Economic Mission to the USA — East Coast, and Tzuri Sisso, consul general of Israel in Miami, highlighted the importance of U.S.–Israel economic and technological cooperation.
A central panel discussion, “Building for Scale: Insights from Global Experts,” focused on growth and global operations. Panelists included Michael B. Greenwald of Amazon Web Services, Amir Mamo of Teva, Adv. Oded Har‑Even of Sullivan & Worcester, Karin Kidron Mor of the Israel Export Institute, and Mark Goldwasser, CEO of Ceros Financial Services. The session was moderated by Yaron Shilat, head of public policy and innovation at Amazon Web Services.
The conference concluded with pitch sessions by the CEOs of the participating Israeli companies, moderated by Adv. Yael Baratz, partner at Pearl Cohen. The sessions gave startups a platform to present directly to members of the U.S. healthcare and investment communities.